14.1 Visit Scheduling and Logistics

Managing Protocol Visit Windows

Visit scheduling is a core operational activity for a Clinical Research Coordinator (CRC). A protocol dictates not only which procedures must occur but when they must occur. Most protocols provide a visit window, defined as a specific timeframe around a target date during which a study visit must be completed. This standardization ensures that efficacy and safety data are collected at consistent intervals across all participants globally.

Target Date Calculation

The baseline or Day 1 visit typically serves as the anchor point for all subsequent visits. When scheduling future visits, the CRC must calculate the target date based on this anchor. For example, if Day 1 is January 1, Day 28 is exactly 27 days later (January 28).

Strict vs. Soft Windows

Visit windows vary significantly depending on the phase and nature of the trial:

Managing Out-of-Window Visits

A visit occurring outside the designated window is a protocol deviation. The CRC must document this deviation, note the reason, and often submit it to the Institutional Review Board (IRB) and the sponsor. It is critical to proactively schedule visits early in the window. By scheduling early, the CRC builds in buffer time. If a patient cancels their appointment due to a flat tire on Day 26 (for a Day 28 ± 3 days window), the CRC still has until Day 31 to reschedule them without triggering a deviation. If the CRC originally scheduled them on Day 31 and they cancel, a deviation is inevitable.

Coordinating Ancillary Services

A CRC rarely works in isolation. An average clinical trial visit requires coordination with multiple ancillary departments within the hospital or clinic. Efficient scheduling requires understanding the lead times and specific workflows of these departments.

Investigational Drug Service (IDS) Pharmacy

The CRC must notify the research pharmacy well in advance to prepare the Investigational Product (IP). Some IPs, particularly biologics or gene therapies, require complex compounding, thawing, or have an incredibly short expiration time once reconstituted (sometimes as short as 60 minutes).

To prevent costly IP waste:

• Wait for Safety Clearance: Preparation should only begin after the subject is physically present, has signed the consent (if a baseline visit), and has passed any required pre-dose safety checks, such as normal vital signs or stat laboratory results.
• Communication: Use real-time communication (secure text, pager, or direct phone call) to alert the pharmacy the moment the patient is cleared for dosing.

Imaging and Radiology

Scans such as MRIs, CTs, and DEXA scans often require insurance pre-authorization (if billed to standard of care) or specific machine calibrations (if billed to the study). Some protocols demand that every scan for a patient be performed on the exact same physical scanner to reduce variability. The CRC must ensure the appointment is booked within the protocol visit window and that the imaging data can be de-identified and uploaded to the sponsor's central imaging vendor in the correct format.

Clinical Trial Management Systems (CTMS)

Many CRCs utilize a CTMS or a master scheduling matrix to trigger automated notifications to ancillary departments 48 to 72 hours before a visit. This ensures that the pharmacy has the necessary IP in stock, the lab has the correct proprietary kits assembled, and the imaging department has the specific protocol parameters loaded into their scanner.

Subject Retention and Unscheduled Visits

Scheduling is intrinsically linked to patient retention. High participant burden—characterized by frequent visits, long clinic wait times, and inflexible scheduling—is one of the primary drivers of participant dropout in clinical research.

Patient-Centric Scheduling Strategies

To maximize retention, the CRC must adopt a patient-centric approach:

• Flexibility: Work around the subject's personal and professional schedule. This may involve offering early morning, late evening, or weekend visits if the site's infrastructure allows.
• Decentralized Trial Elements: Leverage protocol-allowed decentralized methods, such as arranging for home health nurses to conduct basic safety blood draws or vital checks, thereby saving the patient a trip to the clinic.
• Travel Logistics: Ensure that subject travel reimbursements, stipends, or transportation services (like study-provided Ubers or taxis) are arranged seamlessly. A patient should not drop out of a trial simply because they cannot afford parking.

Unscheduled Visits

Protocols account for unscheduled visits, which occur when a participant experiences an adverse event (AE), requires additional laboratory tests for safety monitoring (e.g., following an abnormal liver function test), or loses their IP and needs a replacement bottle.

The CRC must rapidly arrange these visits, ensure the Principal Investigator (PI) or sub-investigator physically assesses the participant, and meticulously document the reason for the unscheduled visit in the source documents and the electronic Case Report Form (eCRF). Unscheduled visits do not typically have windows, as they are reactive to patient needs rather than proactive data collection points.

Missed Visits and Loss to Follow-up

If a subject misses a scheduled visit, the CRC must act immediately. If they cannot be reached, the CRC must execute a documented, escalated communication strategy before classifying the subject as Lost to Follow-up (LTFU). Standard operating procedures usually require:

1. Three phone calls on different days at different times of day.
2. An email or secure message via the patient portal.
3. A final certified letter sent to their last known address. Only after all these attempts fail can the subject be officially marked as LTFU.